医学
卵巢癌
指南
疾病
重症监护医学
妇科癌症
自然史
临床实习
癌症
肿瘤科
妇科
内科学
病理
家庭医学
作者
Andrés Redondo,Eva Guerra,Luís Manso,Cristina Martín-Lorente,Jerónimo Martínez-García,J.A. Pérez-Fidalgo,M. Varela,María Jesús Rubio,Maria-Pilar Barretina-Ginesta,Antonio González-Martín
标识
DOI:10.1007/s12094-020-02545-x
摘要
Abstract Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer remains the leading cause of death from gynecologic cancer. In the last decade, there have been important advances both in systemic and surgical treatment. However, there is no doubt that the incorporation of PARP inhibitors as maintenance after the response to platinum-based chemotherapy, first in recurrent disease and recently also in first line, will change the natural history of the disease. The objective of this guide is to summarize the current evidence for the diagnosis, treatment, and follow-up of ovarian cancer, and to provide evidence-based recommendations for clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI